MRX34
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MRX34, covering 2016-09-27 to 2016-09-27. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacodynamics Study of MRX34, MicroRNA Liposomal Injection in Melanoma Patients With Biopsy Accessible Lesions [Phase 1, Phase 2]